内容紹介
Summary
A 67-year-old woman was diagnosed with StageⅡA breast cancer(T2N0M0)in 2003. She underwent mastectomy and lymph node dissection. Oral fluoropyrimidine was administered for 3 years as adjuvant chemotherapy. In 2008, the patient was diagnosed with multiple bone metastases and left supraclavicular lymph node metastasis. Radiotherapy was performed on the left first rib and left supraclavicular lymph node. She was treated with chemotherapy and endocrine therapy and bone metastasis therapeutic agent. In 2013, multiple liver metastases were noted and treated with chemotherapy. Liver metastases were well-controlled. Endocrine therapy was continued for bone metastases without visceral metastasis. In 2016, the patient was diagnosed with bone marrow carcinomatosis and died 2 weeks later due to bone marrow carcinomatosis.
要旨
症例は67歳,女性。2003年に左乳癌,StageⅡAの診断でBt+Axを施行され,術後補助療法として経口フッ化ピリミジン3年間内服治療が施行された。2008年に骨転移が出現し以後は放射線治療,化学療法で治療を開始され,内分泌療法,骨転移治療剤で維持された。2013年に多発肝転移が出現したが化学療法に変更され,コントロールは良好であった。胸腹部内臓転移はなく骨転移に対して内分泌療法で治療されていたが,2016年に骨髄癌症を発症し14日目に死亡した。
目次
A 67-year-old woman was diagnosed with StageⅡA breast cancer(T2N0M0)in 2003. She underwent mastectomy and lymph node dissection. Oral fluoropyrimidine was administered for 3 years as adjuvant chemotherapy. In 2008, the patient was diagnosed with multiple bone metastases and left supraclavicular lymph node metastasis. Radiotherapy was performed on the left first rib and left supraclavicular lymph node. She was treated with chemotherapy and endocrine therapy and bone metastasis therapeutic agent. In 2013, multiple liver metastases were noted and treated with chemotherapy. Liver metastases were well-controlled. Endocrine therapy was continued for bone metastases without visceral metastasis. In 2016, the patient was diagnosed with bone marrow carcinomatosis and died 2 weeks later due to bone marrow carcinomatosis.
要旨
症例は67歳,女性。2003年に左乳癌,StageⅡAの診断でBt+Axを施行され,術後補助療法として経口フッ化ピリミジン3年間内服治療が施行された。2008年に骨転移が出現し以後は放射線治療,化学療法で治療を開始され,内分泌療法,骨転移治療剤で維持された。2013年に多発肝転移が出現したが化学療法に変更され,コントロールは良好であった。胸腹部内臓転移はなく骨転移に対して内分泌療法で治療されていたが,2016年に骨髄癌症を発症し14日目に死亡した。